TherapeuticsMD, Inc. Earnings Per Share (Basic)
TherapeuticsMD, Inc. (TXMD) reported Earnings Per Share (Basic) of $0.01 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- TherapeuticsMD, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.01, a 80.00% decline year-over-year.
- TherapeuticsMD, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.01.
- TherapeuticsMD, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.05, a 344.72% decline year-over-year.
- TherapeuticsMD, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.01.
- TherapeuticsMD, Inc. earnings per share, basic for fiscal 2025 was -$0.05.
- TherapeuticsMD, Inc. earnings per share, basic for fiscal 2024 was -$0.19.
- TherapeuticsMD, Inc. earnings per share, basic for fiscal 2023 was -$0.99, a 107.98% decline from fiscal 2022.
- TherapeuticsMD, Inc. earnings per share, basic for fiscal 2022 was $12.41.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.01 10-Q · filed 2026-08-11 | $0.02 10-Q · filed 2026-08-11 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2026-03-31 | $0.01 10-Q · filed 2026-05-12 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-08-11 | $0.02 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2025-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-04-01 | $0.01 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.05 10-K/A · filed 2026-04-01 | |
| 2025-09-30 | $0.01 10-Q · filed 2025-11-12 | $0.06 derived: net income ÷ weighted average shares · filed 2026-08-11 | $0.00 10-Q · filed 2025-11-12 | $0.03 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2025-06-30 | $0.05 10-Q · filed 2026-08-11 | -$0.01 10-Q · filed 2026-08-11 | $0.02 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2025-03-31 | -$0.06 10-Q · filed 2026-05-12 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-11 | |
| 2024-12-31 | $0.02 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.19 10-K/A · filed 2026-04-01 | |
| 2024-09-30 | -$0.05 10-Q · filed 2025-11-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.21 10-Q · filed 2025-11-12 | -$3.39 derived: net income ÷ weighted average shares · filed 2025-11-12 | |
| 2024-06-30 | -$0.09 10-Q · filed 2025-08-12 | -$0.16 10-Q · filed 2025-08-12 | $1.07 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$7.89 derived: net income ÷ weighted average shares · filed 2025-11-12 | |
| 2024-03-31 | -$0.06 10-Q · filed 2025-05-13 | $0.17 derived: net income ÷ weighted average shares · filed 2025-11-12 | $1.77 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$16.74 derived: net income ÷ weighted average shares · filed 2025-11-12 | |
| 2023-12-31 | $0.03 derived: net income ÷ weighted average shares · filed 2025-03-27 | $0.43 derived: net income ÷ weighted average shares · filed 2025-03-27 | $2.05 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.99 10-K · filed 2025-03-27 | -$0.98 10-K · filed 2024-03-29 |
| 2023-09-30 | -$0.32 10-Q · filed 2023-11-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$0.92 10-Q · filed 2023-11-14 | $6.80 derived: net income ÷ weighted average shares · filed 2024-08-12 | |
| 2023-06-30 | -$0.24 10-Q · filed 2024-08-12 | -$0.60 10-Q · filed 2024-08-12 | $7.30 derived: net income ÷ weighted average shares · filed 2024-08-12 | $4.41 derived: net income ÷ weighted average shares · filed 2024-08-12 | |
| 2023-03-31 | -$0.37 10-Q · filed 2023-05-15 | $7.70 derived: net income ÷ weighted average shares · filed 2024-08-12 | $4.75 derived: net income ÷ weighted average shares · filed 2024-08-12 | $16.91 derived: net income ÷ weighted average shares · filed 2024-08-12 | |
| 2022-12-31 | $8.20 derived: net income ÷ weighted average shares · filed 2024-03-29 | $5.20 derived: net income ÷ weighted average shares · filed 2024-03-29 | $17.57 derived: net income ÷ weighted average shares · filed 2024-03-29 | $12.41 10-K · filed 2024-03-29 | |
| 2022-09-30 | -$3.13 10-Q · filed 2023-11-14 | $9.25 derived: net income ÷ weighted average shares · filed 2023-11-14 | $3.86 10-Q · filed 2023-11-14 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-11-14 | |
| 2022-06-30 | $12.83 10-Q · filed 2023-08-14 | $7.29 10-Q · filed 2023-08-14 | $2.35 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$3.16 derived: net income ÷ weighted average shares · filed 2023-11-14 | |
| 2022-03-31 | -$5.70 10-Q · filed 2023-05-15 | -$10.72 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$16.33 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$21.74 derived: net income ÷ weighted average shares · filed 2023-11-14 | |
| 2021-12-31 | -$5.02 derived: net income ÷ weighted average shares · filed 2023-04-07 | -$10.63 derived: net income ÷ weighted average shares · filed 2023-04-07 | -$16.04 derived: net income ÷ weighted average shares · filed 2023-04-07 | -$21.66 10-K · filed 2023-04-07 | |
| 2021-09-30 | -$5.62 10-Q · filed 2022-11-14 | -$11.03 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$16.68 10-Q · filed 2022-11-14 | -$2.21 derived: net income ÷ weighted average shares · filed 2022-11-14 | |
| 2021-06-30 | -$5.41 10-Q · filed 2022-08-15 | -$11.06 10-Q · filed 2022-08-15 | -$1.23 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.09 derived: net income ÷ weighted average shares · filed 2022-11-14 | |
| 2021-03-31 | -$5.67 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.60 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.79 derived: net income ÷ weighted average shares · filed 2022-11-14 | |
| 2020-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$0.27 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$0.67 derived: net income ÷ weighted average shares · filed 2022-03-23 | |
| 2020-09-30 | -$0.12 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$0.31 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$0.52 derived: net income ÷ weighted average shares · filed 2021-11-12 | ||
| 2020-06-30 | -$0.19 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$0.40 derived: net income ÷ weighted average shares · filed 2021-08-04 | |||
| 2020-03-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2022-03-23 | ||||
| 2019-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |